Skip to main content
Fig. 7 | Microbial Cell Factories

Fig. 7

From: Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases

Fig. 7

Effects of Siropin on mice fecal proteases. Inhibition of total fecal proteolytic activity (a) and elastolytic activity (b) from DSS-treated mice. Protease activities from mice drinking water alone were considered as 100%. Data are shown as mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001 using Kruskal–Walls with Dunn’s post-test (n = 8 in each group)

Back to article page